IDSA/SHEA guidelines recommend fecal microbiota transplantation for patients with multiple recurrences.
CutisPharma today announced that the US Food and Drug Administration (FDA) has approved Firvanq, the company's vancomycin oral solution for treating Clostridium difficile–associated diarrhea (CDAD) and enterocolitis caused by Staphylococcus aureus, including methicillin-resistant strains.
In what is being called the world's first outbreak of drug-resistant typhoid, more than 100 children are sick and dozens have died in Hyderabad, Pakistan, the country's The News International reported yesterday.
Researchers in France report that a reduction in carbapenem consumption in French hospitals occurred after the release of national guidelines on carbapenem use in 2010, according to a study yesterday in Antimicrobial Resistance and Infection Control. They suggest that further carbapenem reduction could be linked to reduced use of fluoroquinolones and third-generation cephalosporins (3GCs).
A significant decrease in rates of clinically confirmed long-term care facility onset Clostridium difficile infection (CDI) at 132 Veteran's Affairs facilities coincided with implementation of a nationwide prevention initiative, researchers report in a new study in Infection Control and Hospital Epidemiology.
A study yesterday by experts from the US Centers for Disease Control and Prevention (CDC) found that the incidence of Clostridium difficile in long-term care facilities decreased 17.5% annually from 2011 to 2015 at 10 US sites, along with a concomitant decline in inpatient fluoroquinolone use.
Health officials in Los Angeles County today announced the area's first sexually transmitted Zika case, which involves a male resident who traveled to Mexico and had Zika symptoms in early November and his female partner, who did not travel.
A study yesterday in Clinical Infectious Diseases reports high long-term success rates of fecal microbiota transplant (FMT) against recurrent Clostridium difficile infection (CDI).
Emory University researchers contacted all eligible patients who received FMT for recurrent CDI from Jul 1, 2012, to Dec 31, 2016. Of 190 eligible patients, 137 (72%) completed the telephone survey.
A 3-track system would offer key advantages to the FDA's approach, the experts say.
China has detected two new human avian influenza cases, one involving an adult sickened by H7N9 and the other a young child infected with H9N2, according to government reports in the region.
